BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Fluvoxamine

A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.

297+ PubMed studies analyzed · 44 RCTs · Evidence Score: 49.4

Research Domains

Fluvoxamine has been studied across 16 research domains including 🌤️ Mood & Depression, 🧘 Stress & Anxiety, 🧠 Focus & Attention, 😴 Sleep, 🫁 Liver & Detox. The primary research focus is 🌤️ Mood & Depression with 51% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Fluvoxamine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

17
16 shared targets
Lynestrenol
15 shared targets
Toxaphene
14 shared targets
Mestranol
14 shared targets
Flutamide
17 shared targets
Dimethisterone
10 shared targets
Phenelzine
13 shared targets
Polidocanol
12 shared targets
Piperonyl
11 shared targets
Acetaldehyde
10 shared targets
Loading evidence profile...

This evidence profile for Fluvoxamine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.